U.S. Markets closed
LISTEN

Schultz: Businesses need to do more to help people

Yahoo Finance's Julia La Roche sits down with executive chairman and former CEO of Starbucks Howard Schultz

AMAG Pharmaceuticals, Inc. (AMAG)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
18.20-0.25 (-1.36%)
At close: 4:00PM EDT

18.20 0.00 (0.00%)
After hours: 4:42PM EDT

People also watch
ACORALNYAKRXMNTAANAC
  • T
    Thiepe
    Thiepe
    I was really hoping that it wouldn't come cascading down to $16... hopefully it'll find a new support point at $17 or $18.
  • O
    Olivia
    Olivia
    Downside risk pretty much eliminated now I would guess, thoughts? I started receiving notifications from awe-some*sto-cks the other week and so far they have presented interesting new trade ideas.
  • J
    Jasmine
    Jasmine
    Sick of getting crushed in the markets all the time. One free service that really helped my trading is the-stockdork. See what they have to offer at the-stockdork .
  • T
    Thiepe
    Thiepe
    Now that AMAG is trading in the $20 range, will it crash back to $1
  • J
    JasonF
    JasonF
    Anybody have any insight
  • J
    Johnny
    Johnny

    PTN recently expanded their licensing to China. There is also rumor that Merck is interested in a licensing deal for their female HSSD

    https://finance.yahoo.com/news/palatin-technologies-announces-signing-licensing-113000198.html

    Palatin Technologies Announces Signing of Licensing Agreement with Fosun Pharma Rights to Bremelanotide in China and Other Selected Territories
    "Palatin") announced today that it has entered into a collaboration and license agreement with Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd., a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma"), for exclu
    finance.yahoo.com
  • f
    frank
    frank
    Recently lost exclusive contracts in huge NY & FL markets in their oncology arena. Suspected large decreases in revenue Q3 forward.
  • k
    krljdljorpbv
    krljdljorpbv

    This nasdaq stock could be on the verge of greatness. https://seekingalpha.com/article/4045084-long-island-iced-tea-looks-poised-benefit-shift-away-carbonated-beverages

    Long Island Iced Tea Looks Poised To Benefit From Shift Away From Carbonated Beverages
    Long Island Iced Tea is a beverage company that provides premium non-alcoholic ready-to-drink iced tea bottle beverages. The company recently closed a public of
    seekingalpha.com
  • d
    dillois
    dillois
    Down 5% on very low volume - smells like hedgies trying to get folks to sell to start covering some short positions... I'm anticipating a healthy swing in earnings this qtr.
  • K
    Kirsten
    Kirsten
    Who says AMAG isn't poised for potentially massive upward movement? I started receiving notifications from awe*some*stocks the other week and so far they have presented interesting new trade ideas.
  • E
    Ed
    Ed
    Just looking for survivors. Those remaining may want to purchase insurance for what could be a rough ascent...
  • P
    Pharmaheroooooo
    Pharmaheroooooo

    IGXT (MC $50 M) NDA filing for MEGA thin-flim Cialis (better than Viagra) this month =10++ BAGGER Potential ! PLEASE read this guys and then join us to make big money .A LIFETIME OPPORTUNITY HERE GUYS !!!

    2 US-NDA submission within 2 months ,lot of Cash and heavily underpriced at a valuation of just $50 million .1 Big drug partnered with Endo Pharma already under review by FDA market launch expected in 1H 2018 .GL

    Intelgenx (IGXT)

    MarketCap $50 Million
    Cash ~$12 Million (including convertible debt) =cash untill 2021+
    Price: 0.80

    NDA submission for tadalafil (erectile dysfunction) thin-film version of Blockbuster drug Cialis in June or July
    NDA resubmission for Rizaport (migraine) in early Q3
    Partnership for Tadalafil in 2H 2017

    http://www.biotuesdays.com/features/2017/5/11/intelgenx-has-multi-faceted-bd-approach-for-its-oral-films

    IntelGenx previously confirmed the bioequivalence of Tadalafil to Eli Lilly’s Cialis, which had sales of $1.5-billion in 2016 but faces generic competition in 2020. IntelGenx has an exclusive license for oral films from Lilly for its dosing patent, which would allow Tadalafil to enter the ED market in the U.S. free from patent litigation from Lilly. Dr. Matzen explains that Tadalafil, which offers a discrete dosing alternative, could enter the market in 2018, with up to three years of market exclusivity before Cialis is hit with generic competition.

    Tadalafil is an erectile dysfunction (ED) treatment that boasts bioequivalence with Cialis, the current leading brand, and with a successful biostudy in-hand a 505(b)(2) NDA is set to be filed any day now, meaning that a full launch should be expected in mid-2018. Cialis is already winning-out over Viagra in terms of numbers of prescriptions, which is largely down to price and efficacy, but when Tadalafil comes to market with the same product in a more convenient and discreet delivery mechanism, IntelGenX should see a massive number of customers take-up its services.

    IntelGenx has multi-faceted BD approach for its oral films
    With a burgeoning pipeline of pharmaceutical oral films, IntelGenx’s (OTCQX:IGXT; TSXV:IGX) business development strategy is focused on partnering its product pipeline along with actively meeting with potential partners to explore manufacturing
    www.biotuesdays.com
  • R
    Richard
    Richard

    Monster MicroCaps SPECIAL ALERT to AMAG shareholders – NWBO $.19 and climbing, just announced $11 million financing with convertible debt payable in 3 years at $0.25, $.50 and $1.00. NWBO expected to release final Phase III Trial results any day from now until mid-July. If results are comparable to preliminary data, shares likely to explode to yield enormous percentage gains. Announcement could be huge because DCVax-L and DCVax Direct are also proven effective against 13 common cancers and has only mild fever as potential side effect. This breakthrough immunotherapy might replace the $100 Billion chemotherapy market.
    https://finance.yahoo.com/news/nwbio-closes-3-convertible-debt-154100683.html

    NWBio Closes 3-Year Convertible Debt Exchange and Financing, and Completes Payoff of Last $5 Million of 2014 Bonds
    This completes the Company's payoff of $11 million in principal amount of bonds, plus associated interest and forbearance fees, over the period from March through June of this year in accordance with an installment payment agreement with the bondhold
    finance.yahoo.com
  • T
    Thiepe
    Thiepe
    Damn I just bought at $16.30, it'll probably reach a new low today...
  • Y
    Yahoo Finance Insights
    Yahoo Finance Insights
    AMAG reached a new 52 Week Low at 16.00
  • S
    SwingTrader
    SwingTrader
    They don't have funds to cover anymore expenses... Soon will be offering more shares to public or worse to BANKRUPTCY :(((
  • T
    Thiepe
    Thiepe
    Is this a good time to get in or will it be dropping some more?
  • S
    SwingTrader
    SwingTrader
    Bearish
  • Y
    Yahoo Finance Insights
    Yahoo Finance Insights
    AMAG reached a new 52 Week Low at 16.25
  • Y
    Yahoo Finance Insights
    Yahoo Finance Insights
    AMAG reached a new 52 Week Low at 16.40